CI Articles, Cigna Corporation - From 06/26/24

Piper Sandler has initiated coverage on Cigna Corporation (NYSE:CI), a diversified managed care and healthcare delivery organization specializing i...

Cigna Group (NYSE:CI) has outperformed the market over the past 5 years by 2.89% on an annualized basis producing an average annual return of 16.26...

The Cigna Group (NYSE: CI) continues to be aided by two solid growth platforms, acquisitions and a solid financial position. A solid 2024 guidance ...

AbbVie Inc’s (NYSE:ABBV) top-selling arthritis drug, Humira, has managed to retain over 80% of its patients even after facing nine lower-pric...

Cigna Group (NYSE:CI) has outperformed the market over the past 10 years by 3.4% on an annualized basis producing an average annual return of 13.92...

Cigna Group (NYSE:CI) has outperformed the market over the past 10 years by 3.45% on an annualized basis producing an average annual return of 14.3...

On Thursday, Cigna Corporation (NYSE:CI) reported first-quarter sales of $57.26 billion, up 23% Y/Y, beating the consensus of $55.47 billion, p...

Cigna Group (NYSE:CI) has outperformed the market over the past 15 years by 7.82% on an annualized basis producing an average annual return of 19.7...

On Thursday, Evernorth Health Services said its Accredo arm will make a Humira biosimilar available to patients with no out-of-pocket costs. Eve...

Cigna Group (NYSE:CI) has outperformed the market over the past 5 years by 6.21% on an annualized basis producing an average annual return of 18.53...